About metaLead
metaLead is a company based in Basel (Switzerland) founded in 2023. It operates as a B2B. metaLead offers products and services including Metal Capture Candidates, Wilson Disease Treatment, and Lead Poisoning Solution. metaLead operates in a competitive market with competitors including EmeraMed and Captura Biopharma, among others.
- Headquarter Basel, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Metalead Therapeutics Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of metaLead
metaLead offers a comprehensive portfolio of products and services, including Metal Capture Candidates, Wilson Disease Treatment, and Lead Poisoning Solution.
Pharmaceuticals that selectively remove toxic metals like copper.
Targets copper accumulation to prevent organ damage in patients.
Removes lead from blood and organs with high selectivity and efficacy.
Funding Insights of metaLead
Detailed funding history for metaLead
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by metaLead
Investment portfolio details for metaLead
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - metaLead
Detailed financials for metaLead
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metalead Comparisons
Peer comparison for metaLead
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of metaLead
metaLead operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EmeraMed and Captura Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for mercury toxicity treatment are developed by EmeraMed.
|
|
| Locked | Locked | Locked |
Developer of therapeutic to eliminate harmful radioactive material from the body
|
Detailed competitors of metaLead
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metalead
Complete news archive for metaLead
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about metaLead
metaLead was founded in 2023.
metaLead is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
metaLead Therapeutics AG, based in Basel, Switzerland, creates innovative pharmaceutical candidates that selectively capture and remove specific toxic metals from the body. These treatments address conditions like Wilson disease, where copper accumulates, and lead poisoning, improving efficacy over standard care with oral administration and reduced side effects. The company focuses on preclinical research, targeting essential and non-essential metals to enhance patient outcomes without disrupting vital functions.
metaLead's top competitors include EmeraMed and Captura Biopharma.
metaLead offers Metal Capture Candidates, Wilson Disease Treatment, and Lead Poisoning Solution.